Mukul Minocha

1.7k total citations
32 papers, 612 citations indexed

About

Mukul Minocha is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mukul Minocha has authored 32 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mukul Minocha's work include Drug Transport and Resistance Mechanisms (8 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (6 papers). Mukul Minocha is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Lung Cancer Research Studies (8 papers) and Cancer therapeutics and mechanisms (6 papers). Mukul Minocha collaborates with scholars based in United States, Germany and United Kingdom. Mukul Minocha's co-authors include Dhananjay Pal, Varun Khurana, Ashim K. Mitra, Ashim K. Mitra, Bin Qin, Mohamed I. A. Othman, Deep Kwatra, Amit Khatri, Ahmed A. Suleiman and Sulabh Patel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mukul Minocha

31 papers receiving 597 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mukul Minocha	256	151	120	84	75	32	612
Haiqing Dai	343 1.3×	129 0.9×	70 0.6×	82 1.0×	60 0.8×	24	714
Yue-Li Sun	230 0.9×	248 1.6×	42 0.3×	59 0.7×	38 0.5×	23	535
Dennis A. Noe	256 1.0×	333 2.2×	169 1.4×	69 0.8×	42 0.6×	32	871
Christopher Matheny	356 1.4×	109 0.7×	51 0.4×	73 0.9×	99 1.3×	23	695
Abhisek Swaika	549 2.1×	475 3.1×	175 1.5×	89 1.1×	36 0.5×	30	1.1k
Amit Garg	372 1.5×	325 2.2×	153 1.3×	153 1.8×	417 5.6×	39	1.1k
Andrew P. Beelen	235 0.9×	161 1.1×	25 0.2×	115 1.4×	36 0.5×	35	553
Parnian Zia‐Amirhosseini	112 0.4×	142 0.9×	176 1.5×	178 2.1×	69 0.9×	18	747
Radan Spaventi	310 1.2×	380 2.5×	52 0.4×	113 1.3×	78 1.0×	38	850
Taiji Sawamoto	159 0.6×	100 0.7×	27 0.2×	53 0.6×	36 0.5×	30	644

Countries citing papers authored by Mukul Minocha

Since Specialization

Citations

This map shows the geographic impact of Mukul Minocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mukul Minocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mukul Minocha more than expected).

Fields of papers citing papers by Mukul Minocha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mukul Minocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mukul Minocha. The network helps show where Mukul Minocha may publish in the future.

Co-authorship network of co-authors of Mukul Minocha

This figure shows the co-authorship network connecting the top 25 collaborators of Mukul Minocha. A scholar is included among the top collaborators of Mukul Minocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mukul Minocha. Mukul Minocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minocha, Mukul, et al.. (2025). Tarlatamab Exposure–Efficacy and Exposure–Safety Relationships to Inform Dose Selection in Patients with Small Cell Lung Cancer. Clinical Cancer Research. 31(22). 4688–4697.

Kong, Stephanie M.Y., Mukul Minocha, Po‐Wei Chen, et al.. (2025). Population Pharmacokinetics of Tarlatamab, a Half-Life Extended DLL3-Directed Bispecific T-Cell Engager in Patients with Previously Treated Small Cell Lung Cancer. Clinical Pharmacokinetics. 64(5). 729–741. 3 indexed citations

Rodríguez, Luis Paz-Ares, Enriqueta Felip, Myung‐Ju Ahn, et al.. (2024). PP01.72 Randomized Phase-3 Study: Tarlatamab, a DLL3-targeting Bispecific T-cell engager (BiTE), Compared to Standard-of-Care in Relapsed Small Cell Lung Cancer (DeLLphi-304). Journal of Thoracic Oncology. 19(7). e34–e34. 1 indexed citations

Minocha, Mukul, Corbin G. Thompson, Yanchen Zhou, et al.. (2024). Pharmacokinetics of Tarlatamab, a Delta-Like Ligand-3 (DLL3) Targeted Half-Life Extended Bispecific T-Cell Engager (BiTE®) Immunotherapy in Adult Patients with Previously Treated Small-Cell Lung Cancer: Results from DeLLphi-300, a Phase I Multiple-Dose-Escalation Study. Clinical Pharmacokinetics. 63(12). 1757–1768. 5 indexed citations

Dowlati, Afshin, Lauren A. Byers, Melissa L. Johnson, et al.. (2021). 1668TiP Phase Ib study of AMG 757, a half-life extended bispecific T-cell engager immuno-oncology therapy, combined with AMG 404, an anti-PD-1 antibody, in patients with small cell lung cancer (SCLC). Annals of Oncology. 32. S1172–S1173. 3 indexed citations

Tran, Ben, Lisa G. Horvath, Tanya B. Dorff, et al.. (2020). 609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC). Annals of Oncology. 31. S507–S507. 42 indexed citations

Minocha, Mukul, Hong Li, Yi‐Lin Chiu, David Carter, & Mohamed I. A. Othman. (2019). Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials. Clinical and Translational Science. 12(5). 470–480. 10 indexed citations

Suleiman, Ahmed A., Mukul Minocha, Amit Khatri, Yinuo Pang, & Mohamed I. A. Othman. (2019). Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials. Clinical Pharmacokinetics. 58(10). 1309–1321. 34 indexed citations

Nader, Ahmed, Mukul Minocha, & Mohamed I. A. Othman. (2019). Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus. Clinical Pharmacokinetics. 59(3). 335–347. 5 indexed citations

10.

Minocha, Mukul, Jiewei Zeng, Jan Paul Medema, & Mohamed I. A. Othman. (2018). Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus. Clinical Pharmacokinetics. 57(9). 1185–1198. 10 indexed citations

11.

Minocha, Mukul, Jonathan Q. Tran, James P. Sheridan, & Ahmed A. Othman. (2015). Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials. Clinical Pharmacokinetics. 55(1). 121–130. 8 indexed citations

12.

Vaishya, Rakesh Chandra, et al.. (2014). Topical nanomicelles for the treatment of intermediate and posterior uveitis:Focus on micelle size. Investigative Ophthalmology & Visual Science. 55(13). 5266–5266. 1 indexed citations

13.

Khurana, Varun, Mukul Minocha, Dhananjay Pal, & Ashim K. Mitra. (2014). Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors. Drug metabolism and drug interactions. 29(3). 179–190. 35 indexed citations

14.

Khurana, Varun, Mukul Minocha, Dhananjay Pal, & Ashim K. Mitra. (2014). Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Drug metabolism and drug interactions. 29(4). 249–259. 31 indexed citations

15.

Vaishya, Ravi, Mitan Gokulgandhi, Sulabh Patel, Mukul Minocha, & Ashim K. Mitra. (2014). Novel Dexamethasone-Loaded Nanomicelles for the Intermediate and Posterior Segment Uveitis. AAPS PharmSciTech. 15(5). 1238–1251. 48 indexed citations

16.

Minocha, Mukul, Varun Khurana, & Ashim K. Mitra. (2012). Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography–tandem mass spectrometry (LC/MS–MS). Journal of Chromatography B. 901. 85–92. 43 indexed citations

17.

Minocha, Mukul, Varun Khurana, Bin Qin, Dhananjay Pal, & Ashim K. Mitra. (2012). Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib. International Journal of Pharmaceutics. 436(1-2). 127–134. 53 indexed citations

18.

Minocha, Mukul, Deep Kwatra, Dhananjay Pal, et al.. (2011). Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats. International Journal of Pharmaceutics. 413(1-2). 44–50. 20 indexed citations

19.

Pal, Dhananjay, et al.. (2010). Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sciences. 88(21-22). 959–971. 76 indexed citations

20.

Hariharan, S., Mukul Minocha, Gyan Prakash Mishra, et al.. (2009). Interaction of Ocular Hypotensive Agents (PGF2α Analogs—Bimatoprost, Latanoprost, and Travoprost) With MDR Efflux Pumps on the Rabbit Cornea. Journal of Ocular Pharmacology and Therapeutics. 25(6). 487–498. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact